Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn L Stanfield

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Science Advances|June 11, 2020
Structural basis of broad HIV neutralization by a vaccine-induced cow antibodyRobyn L Stanfield, Zachary T Berndsen, Ruiqi Huang, et al.
Journal of Molecular Biology|June 8, 2002
Contrasting IgG structures reveal extreme asymmetry and flexibilityErica Ollmann Saphire, Robyn L Stanfield, M D Max Crispin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 17, 2008
A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120Alfredo Menendez, Daniel A Calarese, Robyn L Stanfield, et al.
Journal of the American Chemical Society|June 6, 2023
Divergent Total Synthesis and Characterization of MaxamycinsMaxwell J Moore, Pengjin Qin, D Jamin Keith, et al.
Journal of Virology|June 27, 2014
Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopyCharles D Murin, Jean-Philippe Julien, Devin Sok, et al.
Journal of Virology|March 3, 2004
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5Michael B Zwick, H Kiyomi Komori, Robyn L Stanfield, et al.
NPJ Vaccines|April 20, 2026
Structural and genetic signatures of two classes of HCV E2 neutralizing face antibodies from non-human primates immunized with a recombinant E1E2Yen T K Nguyen, Fang Chen, Erick Giang, et al.
Nature Communications|May 12, 2021
Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccinesLinling He, Anshul Chaudhary, Xiaohe Lin, et al.
The Journal of Biological Chemistry|November 13, 2004
A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3Martin Hülsmeyer, Patrick Chames, Roman C Hillig, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2005
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12Daniel A Calarese, Hing-Ken Lee, Cheng-Yuan Huang, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Science Advances|June 11, 2020
Structural basis of broad HIV neutralization by a vaccine-induced cow antibodyRobyn L Stanfield, Zachary T Berndsen, Ruiqi Huang, et al.
Journal of Molecular Biology|June 8, 2002
Contrasting IgG structures reveal extreme asymmetry and flexibilityErica Ollmann Saphire, Robyn L Stanfield, M D Max Crispin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 17, 2008
A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120Alfredo Menendez, Daniel A Calarese, Robyn L Stanfield, et al.
Journal of the American Chemical Society|June 6, 2023
Divergent Total Synthesis and Characterization of MaxamycinsMaxwell J Moore, Pengjin Qin, D Jamin Keith, et al.
Journal of Virology|June 27, 2014
Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopyCharles D Murin, Jean-Philippe Julien, Devin Sok, et al.
Journal of Virology|March 3, 2004
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5Michael B Zwick, H Kiyomi Komori, Robyn L Stanfield, et al.
NPJ Vaccines|April 20, 2026
Structural and genetic signatures of two classes of HCV E2 neutralizing face antibodies from non-human primates immunized with a recombinant E1E2Yen T K Nguyen, Fang Chen, Erick Giang, et al.
Nature Communications|May 12, 2021
Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccinesLinling He, Anshul Chaudhary, Xiaohe Lin, et al.
The Journal of Biological Chemistry|November 13, 2004
A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3Martin Hülsmeyer, Patrick Chames, Roman C Hillig, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2005
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12Daniel A Calarese, Hing-Ken Lee, Cheng-Yuan Huang, et al.
Pageof 12